Ads
related to: neupogen cost per dose- Biosimilar FAQs
See FAQs to help you
understand biosimilars
- Biosimilar Benefits
Learn about Biosimilars and
the future of accessible medicines
- Amneal PATHways®
Get resources & services to support
accessibility for patients
- Biosciences Products
Learn more about our
biosimilar injectables
- Biosimilar FAQs
Search results
Results from the WOW.Com Content Network
Oncologists in the US have also used the BEACOPP regimen relatively less for cost reasons: Twice as many infusion per cycle relative to ABVD; Requirement for G-CSF support, which was under patent protection in the US as late as 2013 (as Neupogen by Amgen), [4] while that patent protection expired in the EU in 2008; [5]
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. [21] Low neutrophil counts may occur with HIV/AIDS , following chemotherapy or radiation poisoning , or be of an unknown cause. [ 21 ]
A tenth, approved in November, is predicted to run about $3.8 million, just shy of the most expensive, also approved last year, which costs $4.25 million a dose.
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
For premium support please call: 800-290-4726 more ways to reach us
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
The Food and Drugs Administration (FDA) first approved filgrastim on February 20, 1991 marketed by Amgen with the brand name Neupogen. [31] It was initially approved to reduce the risk of infection in patients with non-myeloid malignancies who are taking myelosuppressive anti-cancer drugs associated with febrile neutropenia with fever.
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Ads
related to: neupogen cost per dose